A free online personalised cancer medicine resource and decision-making tool is one of the first winners of GE Healthcare's Healthy Imagination Cancer Challenge.

My Cancer Genome is aimed at doctors, patients, carers and researchers and gives up-to-date information on what mutations make cancers grow and their related therapeutic implications.

Developed by Vanderbilt University in Tennessee it also provides information on available clinical trials and matches tumour mutations to therapies.

The site is managed by the Vanderbilt-Ingram Cancer Center, whose work on breast cancer clinical trial design was also one of winners of the Healthy Imagination Cancer Challenge.

The two projects, along with work by the University of Akron on breast reconstruction, the Moffitt Cancer Center on genetic 'modifier' genes and Fred Hutchinson Cancer Research Center on cancer identification, will each receive grants of $100,000.

The winners were selected from more than 500 entries to GE's $100m Healthy Imagination Cancer Challenge, which aims to help doctors find cancer earlier, make more accurate cancer diagnoses, and choose the best possible treatment based on each patient's unique cancer.

Beth Comstock, GE's senior vice president and chief marketing officer, said: "We launched the challenge as a call to action for oncology researchers, businesses, and other innovators around the world to accelerate innovation and help stop this deadly disease.

"It is often challenging for early-stage research to grab the attention of seed investors. The challenge has shown us that there are a remarkable number of breakthrough ideas out there that deserve promotion, investment, and incubation."

The healthcare company will provide each winner with mentoring and access to GE researchers and industry thought leaders as well as the opportunity to “expand partnerships” in the future.

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more